Fleifil et al. recently reported the <i>DNAJB1</i>::<i>PRKACA</i> fusion in 70% of hepatoblastomas (HB), suggesting its diagnostic relevance beyond fibrolamellar carcinoma (FLC). The gene discussed is DNAJB1; the disease is fibrolamellar hepatocellular carcinoma.